Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_assertion type Assertion NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_head.
- NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_assertion description "[The aim was to explore the utility for staging and prognostic impact of carcinoembryonic antigen (CEA), cytokeratin 20 (CK20), guanylyl cyclase C (GCC), CUB (complement protein subcomponents C1r/C1s, urchin embryonic growth factor, and bone morphogenic protein 1) containing domain protein 1 (CDCP1) and mucin 2 (MUC2) mRNA levels in mesenteric lymph nodes of colorectal cancer (CRC) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_provenance.
- NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_assertion evidence source_evidence_literature NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_provenance.
- NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_assertion SIO_000772 21618511 NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_provenance.
- NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_assertion wasDerivedFrom befree-2016 NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_provenance.
- NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_assertion wasGeneratedBy ECO_0000203 NP897374.RA792AfX2ph27_q_3G4Ptv9Pv_XhUM8R_Kz_ZM0mZvBlU130_provenance.